Contract 36F79725D0226
Eli Lilly And Company · Department Of Veterans Affairs · September 17, 2025
Eli Lilly And Company was awarded a federal contract by Department Of Veterans Affairs on September 17, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 16 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on April 3, 2026. If all options are exercised, the contract could reach $8.00 billion.
Contract details
- PIID
- 36F79725D0226
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 17, 2025
- Latest action
- April 3, 2026
Description
TPR.
Modification timeline
-
April 3, 2026Mod P00016$0
-
April 1, 2026Mod P00015NPS ADDITION.$0
-
March 18, 2026Mod P00013NON-TAA$0
-
March 5, 2026Mod P00014DELETION.$0
-
February 19, 2026Mod P00012PPR.$0
-
February 13, 2026Mod P000112026 SUBPLAN.$0
-
January 26, 2026Mod P00010NPS ADDITION.$0
-
January 22, 2026Mod P00009ADDITION.$0
-
January 8, 2026Mod P00008SAF$0
-
January 6, 2026Mod P00006$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $184.3K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79725D0226?
Contract 36F79725D0226 is a federal contract awarded to Eli Lilly And Company by Department Of Veterans Affairs on September 17, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 16 times since the base award.
Who won contract 36F79725D0226?
Eli Lilly And Company won contract 36F79725D0226 from Department Of Veterans Affairs.
How much is contract 36F79725D0226 worth?
Contract 36F79725D0226 has obligated $0 to date but carries a potential ceiling of $8.00 billion if fully funded and all options are exercised.